Alnylam Grants Qiagen License to Kreutzer-Limmer Patents
News Sep 22, 2005
Alnylam Pharmaceuticals, Inc. has announced that it has granted Qiagen N.V. a non-exclusive license to provide research products and services in RNA interference under the Kreutzer-Limmer patent family.
This patent family, owned by Alnylam, covers small interfering RNAs and their use to mediate RNAi in mammalian cells.
"We are very pleased to announce that Qiagen has taken a license to Alnylam's Kreutzer-Limmer patent family," said Vincent Miles, Ph.D., Senior Vice President, Business Development of Alnylam Pharmaceuticals.
"Because Qiagen already has one of the four co-exclusive licenses for research products under the 'Tuschl' patent applications, this agreement emphasizes the importance of the Kreutzer-Limmer patent family for any commercialization of siRNAs."
"Alnylam intends to continue leveraging its leading intellectual property estate through partnerships that create value."
"Qiagen is a leading supplier of siRNA libraries and high throughput siRNA synthesis technology," said Dr. Ulrich Schriek, Qiagen's Vice President Corporate Business Development.
"This license agreement with Alnylam further strengthens Qiagen’s position as a key licensed supplier of siRNAs to the scientific community."
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Gene Regulator May Contribute to Protein Pileup in Exfoliation GlaucomaNews
Researchers are seeking factors that contribute to protein pileup in exfoliation glaucomaREAD MORE
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE